Xinyu Mei

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 02, 2026
PET/CT-Guided Neoadjuvant Tislelizumab plus Chemotherapy/Chemoradiotherapy for Resectable Esophageal Squamous Cell Carcinoma: RATIONALE-213 Final Analysis.

Yushang Yang, Xiaolong Yan, Hongjing Jiang

|Oct 06, 2025
Correction: CD49a+ NK cells promote esophageal cancer development by inducing MDSCs infiltration via GM-CSF.

Kele Cui, Shouxin Hu, Yanfang Zha

|May 28, 2025
CD49a+ NK cells promote esophageal cancer development by inducing MDCSs infiltration via GM-CSF.

Kele Cui, Shouxin Hu, Yanfang Zha

|Sep 01, 2024
Exosomes in esophageal cancer: Promising nanocarriers in cancer progression, diagnosis, prognosis, and therapy.

Ligong Yuan, Haoran Ji, Yang Cao

|Jan 13, 2022
Reciprocal modulation of long noncoding RNA EMS and p53 regulates tumorigenesis.

Chenfeng Wang, Yang Yang, Xianning Wu

Pageof 1